Use of speed and extent of PSA response during the first three cycles of docetaxel chemotherapy in metastatic castrate-resistant prostate cancer to predict overall survival.
Rebecca B. Goody
No relevant relationships to disclose
Darren M. Mitchell
No relevant relationships to disclose
Jonathan McAleese
No relevant relationships to disclose
Joe M. O'Sullivan
No relevant relationships to disclose